Search for other papers by Patrick W. Owens in
Google Scholar
PubMed
Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom
Search for other papers by Terri P. McVeigh in
Google Scholar
PubMed
Search for other papers by Eoin J. Fahey in
Google Scholar
PubMed
Search for other papers by Marcia Bell in
Google Scholar
PubMed
Search for other papers by Denis S. Quill in
Google Scholar
PubMed
Search for other papers by Michael J. Kerin in
Google Scholar
PubMed
Search for other papers by Aoife J. Lowery in
Google Scholar
PubMed
impairment, or sialadenitis. More significant complications include impairment of haematopoiesis and gonadal function and increased risk for second primary malignancies, both solid and haematological. A dose of 100 mCi (3.7 GBq) of radioiodine has been
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Search for other papers by Pi-Ling Chiang in
Google Scholar
PubMed
Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Sheng-Dean Luo in
Google Scholar
PubMed
Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Yen-Hsiang Chang in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Chen-Kai Chou in
Google Scholar
PubMed
Departments of Surgery, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Shun-Yu Chi in
Google Scholar
PubMed
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Search for other papers by Yi-Fan Chen in
Google Scholar
PubMed
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Department of Radiology, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan
School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung City, Taiwan
Search for other papers by Wei-Che Lin in
Google Scholar
PubMed
/FLUS) category, known as Bethesda category III, has been ascribed a malignancy risk of 5–15% ( 2 , 3 , 4 , 5 ). According to international guidelines, Bethesda III thyroid nodules are not considered an indication of radiofrequency ablation (RFA) ( 6 , 7
Search for other papers by Rima Bėrontienė in
Google Scholar
PubMed
Search for other papers by Edita Jašinskienė in
Google Scholar
PubMed
Search for other papers by Rosita Kiudelienė in
Google Scholar
PubMed
Search for other papers by Gintaras Kuprionis in
Google Scholar
PubMed
Search for other papers by Jurgita Makštienė in
Google Scholar
PubMed
Search for other papers by Raminta Macaitytė in
Google Scholar
PubMed
Search for other papers by Dalia Marčiulionytė in
Google Scholar
PubMed
Search for other papers by Lina Poškienė in
Google Scholar
PubMed
Search for other papers by Agnė Šemetaitė in
Google Scholar
PubMed
Search for other papers by Vygantas Šidlauskas in
Google Scholar
PubMed
Search for other papers by Raimondas Valickas in
Google Scholar
PubMed
Search for other papers by Rimantas Žalinkevičius in
Google Scholar
PubMed
Institute of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania
Search for other papers by Rasa Verkauskienė in
Google Scholar
PubMed
deficiency [ 9 ]. Both of these risk factors were present in Lithuania at certain time periods, i.e. the radioactive cloud after the Chernobyl accident passed over the territory, and Lithuania was considered to be a mild to moderate iodine-deficient zone up
Search for other papers by Kristine Z Swan in
Google Scholar
PubMed
Search for other papers by Johnson Thomas in
Google Scholar
PubMed
Search for other papers by Viveque E Nielsen in
Google Scholar
PubMed
Search for other papers by Marie Louise Jespersen in
Google Scholar
PubMed
Search for other papers by Steen J Bonnema in
Google Scholar
PubMed
stratification of thyroid nodules, of which only few are malignant ( 3 ). Therefore, clinicians must balance the risk of overlooking malignancy while reducing the number of unnecessary biopsies in order to avoid overtreatment of benign nodules. If a biopsy is
Guided Therapeutics (GTx) Program, Techna Institute, University Health Network, Toronto, Ontario, Canada
Search for other papers by Axel Sahovaler in
Google Scholar
PubMed
Unit of Otorhinolaryngology – Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiologic Sciences, and Public Health, University of Brescia, Brescia, Italy
Section of Otorhinolaryngology – Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy
Search for other papers by Marco Ferrari in
Google Scholar
PubMed
Search for other papers by Jonathan Athayde in
Google Scholar
PubMed
Search for other papers by Adrian Mendez in
Google Scholar
PubMed
Search for other papers by Kevin Fung in
Google Scholar
PubMed
Search for other papers by John Yoo in
Google Scholar
PubMed
Search for other papers by Anthony C. Nichols in
Google Scholar
PubMed
Search for other papers by S. Danielle MacNeil in
Google Scholar
PubMed
Dear Editor, The recently published “Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer” (WDTC) by Chan et al. [ 1 ] aimed to focus on tumors between 1 and 4 cm, which represent the
Search for other papers by Pedro Weslley Souza Rosario in
Google Scholar
PubMed
. References 1 Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L: European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: The EU-TIRADS. Eur Thyroid J 2017; 6: 225–237. 10
Department of Surgery, County Hospital Ryhov, Jönköping, Sweden
Search for other papers by Johannes Järhult in
Google Scholar
PubMed
Search for other papers by Ramtin Vedad in
Google Scholar
PubMed
, Sugawara M: Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 1994;18:495-499. 10.1007/BF00353745 7725734 20 Rios A, Rodriguez JM, Canteras M, Galindo PJ, Balsalobre MD, Parrilla P: Risk factors for malignancy in
Search for other papers by Mathieu Spaas in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Search for other papers by Annouschka Laenen in
Google Scholar
PubMed
Search for other papers by Jaak Billen in
Google Scholar
PubMed
Search for other papers by Sandra Nuyts in
Google Scholar
PubMed
account biochemical disease recurrence or persistence without structural evidence of malignancy. As research into improving prognostication in DTC patients continues, the ATA has recently introduced the concept of dynamic risk stratification. Furthermore
Search for other papers by Rachelle P Mendoza in
Google Scholar
PubMed
Search for other papers by Richard Cody Simon in
Google Scholar
PubMed
Search for other papers by Nicole A Cipriani in
Google Scholar
PubMed
Search for other papers by Tatjana Antic in
Google Scholar
PubMed
, along with recommended follow-up management based on risk of malignancy ( 1 ). A large majority (65–75%) of thyroid nodules are benign ( 2 ); however, several studies have confirmed a minor yet nonnegligible 1–10% risk of a false-negative cytologic
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Alexander Gorshtein in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Ilana Slutzky-Shraga in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Eyal Robenshtok in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Carlos Benbassat in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Dania Hirsch in
Google Scholar
PubMed
. Nodules are divided into 6 diagnostic categories with different implied risk of malignancy (ROM) and clinical management guidelines [ 1 ]. According to the original classification, Bethesda III (B3) nodules have a relatively low (5–15%) ROM and might be